Answers are grounded in this paper and cite their sources.
Analysis reveals CDP-choline may reduce anxiety and hormonal levels in rats with nicotine dependence, suggesting therapeutic potential.
CDP-choline mitigates the biochemical and behavioral disturbances associated with e-cigarette exposure and withdrawal, highlighting its potential as a therapeutic strategy for nicotine dependence. Future studies incorporating pharmacokinetic profiling, long-term efficacy assessment, and inclusion of female subjects are warranted to further clarify its mechanisms and clinical applicability.
No takes yet. Share an insight, caveat, or question.
Luay Abu-Qatouseh (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: